Dyspnea - A Bad Prognosis Symptom at the End of Life

被引:23
作者
Cuervo Pinna, Miguel Angel [1 ]
Mota Vargas, Rafael [1 ]
Redondo Moralo, Maria Jose [1 ]
Sanchez Correas, Miguel Angel [1 ]
Pera Blanco, Guillem [2 ]
机构
[1] Palliat Care Team Badajoz, Reg Palliat Care Program Extremadura, Badajoz, Spain
[2] Statistician Unitat Suport Recerca Ambit Barcelon, Barcelona, Spain
关键词
dyspnea; place of death; sedation; average survival time; TERMINALLY-ILL PATIENTS; ADVANCED CANCER-PATIENTS; PALLIATIVE-CARE; SURVIVAL; DEATH; PREDICTORS; LENGTH; PLACE; HOME;
D O I
10.1177/1049909108327588
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purposes: Dyspnea as refractory symptom leading to sedation at the end of life and the place of death. Survival study in population with dyspnea. Methods: Longitudinal study of terminally ill patients in a year (n = 195). We divided populations as (a) population with dyspnea: prevalent and incident dyspnea and (b) population without dyspnea. We used the statistical program Stata9 (Kaplan-Meier and Cox logistic regression models). Results: The probability of being sedated was 5 times higher in population with dyspnea. Dying in hospital odds ratio was 2.13 in patients with dyspnea. The average survival time was 52 days in patients with dyspnea and 69 in non-dyspnea patients. The average survival was similar between both groups. Patients with incident dyspnea showed a higher average survival than those with prevalent dyspnea. Conclusions: The connection between dyspnea and sedation was clearly shown. There were significant differences between prevalent dyspnea and incident dyspnea groups.
引用
收藏
页码:89 / 97
页数:9
相关论文
共 35 条
[1]  
[Anonymous], PALL CAR SOL FACTS
[2]   The etiology and management of intractable breathlessness in patients with advanced cancer: a systematic review of pharmacological therapy [J].
Booth, Sara ;
Moosavi, Shakeeb H. ;
Higginson, Irene J. .
NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (02) :90-100
[3]   ...And fashionable screening [J].
Brazil, M .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (01) :6-6
[4]  
Bruera E, 1991, J Palliat Care, V7, P6
[5]   Predictors of home death in palliative care cancer patients [J].
Cantwell, P ;
Turco, S ;
Brenneis, C ;
Hanson, J ;
Neumann, CM ;
Bruera, E .
JOURNAL OF PALLIATIVE CARE, 2000, 16 (01) :23-28
[6]   DYING OF CANCER - THE PLACE OF DEATH AND FAMILY CIRCUMSTANCES [J].
CATALANFERNANDEZ, JG ;
PONSSUREDA, O ;
RECOBERMARTINEZ, A ;
AVELLAMESTRE, A ;
CARBONEROMALBERTI, JM ;
BENITOOLIVER, E ;
GARAULLINAS, I .
MEDICAL CARE, 1991, 29 (09) :841-852
[7]   Survival of Medicare patients after enrollment in hospice programs [J].
Christakis, NA ;
Escarce, JJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (03) :172-178
[8]   Symptom prevalence in the last week of life [J].
Conill, C ;
Verger, E ;
Henriquez, I ;
Saiz, N ;
Espier, M ;
Lugo, F ;
Garrigos, A .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1997, 14 (06) :328-331
[9]  
CUERVO MA, 2006, MED PAL S1, V13, P98
[10]   ESTIMATING LENGTH OF SURVIVAL IN END-STAGE CANCER - A REVIEW OF THE LITERATURE [J].
DENDAAS, N .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1995, 10 (07) :548-555